Tranilast ameliorates experimental mesangial proliferative glomerulonephritis

Nephron - Experimental Nephrology

Volumn 109, Issue 1, 2008, Pages

  Tokuyama, Hirobumi ^a   Kelly, Darren J ^a   Cox, Alison ^a   Zhang, Yuan ^a   Thai, Kerri ^c,d   Nikolic Paterson, David J ^b   Gilbert, Richard E ^a,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cell proliferation; Mesangial cells; Platelet derived growth factor; Tranilast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 7; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; TRANILAST; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY MASS; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; MALE; RATS; RATS, WISTAR;

EID: 46349104473     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000131752     Document Type: Article

References (40)

1. Levy M, Berger J: Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988;12:340-347.
2. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC: A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003;18:1541-1548.
3. Gesualdo L, Di Paolo S, Milani S, Pinzani M, Grappone C, Ranieri E, Pannarale G, Schena FP: Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest 1994;94:50-58.
4. Matsuda M, Shikata K, Makino H, Sugimoto H, Ota K, Akiyama K, Hirata K, Ota Z: Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis. Am J Nephrol 1997;17:25-31.
5. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-1416.
6. Jefferson JA, Johnson RJ: Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 1999;12:297-307.
7. Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjic N: Novel approach to specific growth factor inhibition in vivo - antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 1999;154:169-179.
8. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ: PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 2001;59:1324-1332.
9. Chen YM, Wu KD, Tsai TJ, Hsieh BS: Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells. J Mol Cell Cardiol 1999;31:773-783.
10. Miyazawa N, Umemura K, Kondo K, Nakashima M: Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat. J Cardiovasc Pharmacol 1997;30:157-162.
11. Di Sario A, Bendia E, Svegliati Baroni G, Ridolfi F, Casini A, Ceni E, Saccomanno S, Marzioni M, Trozzi L, Sterpetti P, Taffetani S, Benedetti A: Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J Hepatol 2002;37:584-591.
12. Miyajima A, Asano T, Asano T, Yoshimura I, Seta K, Hayakawa M: Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 2001;165:1714-1718.
13. Kelly DJ, Zhang Y, Gow R, Gilbert RE: Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model. J Am Soc Nephrol 2004;15:2619-2629.
14. Watanabe S, Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Hashimoto H, Umemura K: Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Br J Pharmacol 2000;130:307-314.
15. Mason DW, Williams AF: The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J 1980;187:1-20.
16. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-599.
17. Kakizaki Y, Kraft N, Atkins RC: Differential control of mesangial cell proliferation by interferon-gamma. Clin Exp Immunol 1991;85:157-163.
18. Nikolic-Paterson DJ, Jun Z, Tesch GH, Lan HY, Foti R, Atkins RC: De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis. J Am Soc Nephrol 1996;7:1006-1014.
19. Iwata J, Nishikaze O: New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. Clin Chem 1979;25:1317-1319.
20. Larsen K: Creatinine assay by a reaction-kinetic principle. Clin Chim Acta 1972;41:209-217.
21. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE: Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. J Clin Invest 1997;99:1016-1027.
22. Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ: Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol 1997;151:141-150.
23. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997;45:1559-1565.
24. Lehr HA, van der Loos CM, Teeling P, Gown AM: Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 1999;47:119-126.
25. Waldherr R, Noronha IL, Niemir Z, Kruger C, Stein H, Stumm G: Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 1993;7:471-478.
26. Abboud HE: Growth factors in glomerulonephritis (clinical conference). Kidney Int 1993;43:252-267.
27. Floege J, Johnson RJ: Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 1995;21:271-282.
28. Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006;116:288-296.
29. D'Amico G: Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-237.
30. Bokemeyer D, Panek D, Kramer HJ, Lindemann M, Kitahara M, Boor P, Kerjaschki D, Trzaskos JM, Floege J, Ostendorf T: In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2002;13:1473-1480.
31. Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA: Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int 2004;66:1774-1784.
32. Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ: Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 1999;56:932-943.
33. Gaedeke J, Noble NA, Border WA: Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney Int 2005;68:2042-2049.
34. Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH: Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 2006;70:682-689.
35. Border WA, Brees D, Noble NA: Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 1994;107:140-145.
36. Mifsud S, Kelly DJ, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE: Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron 2003;95:83-91.
37. Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J: The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J Am Soc Nephrol 2002;13:658-667.
38. Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G: Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003;14:1816-1824.
39. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015-8020.
40. Soma J, Sato K, Saito H, Tsuchiya Y: Effect of tranilast in early-stage diabetic nephropathy. Nephrol Dial Transplant 2006;21:2795-2799.